Drug Information

Drug General Information
Drug ID
D0O7WT
Former ID
DNC010206
Drug Name
9-[2-(1-Phosphonobutan-2-yloxy)ethyl]hypoxanthine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530305]
Structure
Download
2D MOL

3D MOL
Formula
C11H17N4O5P
Canonical SMILES
CCC(CP(=O)(O)O)OCCN1C=NC2=C1NC=NC2=O
InChI
1S/C11H17N4O5P/c1-2-8(5-21(17,18)19)20-4-3-15-7-14-9-10(15)12-6-13-11(9)16/h6-8H,2-5H2,1H3,(H,12,13,16)(H2,17,18,19)
InChIKey
WLWRLYCRISPQDH-UHFFFAOYSA-N
PubChem Compound ID
45101449
Target and Pathway
Target(s) Hypoxanthine-guanine phosphoribosyltransferase Target Info Inhibitor [530305]
KEGG Pathway Purine metabolism
Drug metabolism - other enzymes
Metabolic pathways
PathWhiz Pathway Purine Metabolism
Reactome Purine salvage
WikiPathways Nucleotide Metabolism
Mesodermal Commitment Pathway
Endoderm Differentiation
Metabolism of nucleotides
References
Ref 530305Bioorg Med Chem. 2009 Sep 1;17(17):6218-32. Epub 2009 Jul 25.Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Ref 530305Bioorg Med Chem. 2009 Sep 1;17(17):6218-32. Epub 2009 Jul 25.Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.